Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2020
Reporting Period: The filing addresses events occurring between July 31, 2020, and August 13, 2020.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a regulatory notification regarding stock listing status.
Material Changes
The Company received written notification from The Nasdaq Stock Market Listing Qualifications Staff confirming that it has regained compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market.
- Requirement: Nasdaq Listing Rule 5550(a)(2) requires a minimum closing bid price of $1.00 per share.
- Compliance Period: The closing bid price was at or above $1.00 per share for 10 consecutive business days (July 31, 2020, to August 13, 2020).
- Status: The matter regarding the listing deficiency is now closed.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items beyond the resolution of the listing compliance issue.
Investor Verification Checklist
- Verify the current trading status of common stock (Symbol: ACHV) on The Nasdaq Capital Market.
- Confirm the closing bid price history for the period of July 31, 2020, through August 13, 2020.
- Review prior 8-K filings to understand the context of the previous listing deficiency that was resolved by this report.